Experiments have shown that hemoglobin associated acetaldehyde (HBAA) and plasma associated acetaldehyde (PAA) as measured by a fluorigenic high performance liquid chromatographic assay normalized to protein concentration can serve as markers in humans for ethanol intake with different biological kinetics. Additional experiments in animal models (C57 mice and miniature swine) have confirmed these observations and indicated that use of the same assay system to measure platelet associated acetaldehyde (PLTAA) and whole blood associated acetaldehyde (WBAA) provides assessments of ethanol intake as well. The present proposal is designed to define the clinical utility of the above four assays as markers for ethanol intake. Ongoing studies with Schick Health Services assure availability of samples such that assays can be evaluated in well characterized groups of teetotallers, social drinkers, alcoholics, and pregnant women. We have also applied for and received over 10,000 plasma samples from the NICHD-Diabetes and Early Pregnancy Study to help in the definition of the utility of these assays in this latter population. Thus it will be possible to determine norms for the assays involved by age and gender, the statistical significance of discrimination for each assay between drinkers, nondrinkers, and alcoholics as well as correlation with another measure of drinking behavior (the SAAST), and also evaluate special subgroups. Specific studies are designed to determine the chemical nature of the adducts measured by the assay, the biological on and off rates of each assay, as well as precision, recovery, optimum conditions for sample storage and shipping. The development of two animal models will be continued in our own laboratories (the C57 mouse) and in collaboration with investigators at the University of Missouri (miniature swine). The availability of these animal models will allow definition of questions concerning the assays which are difficult to perform in humans including gender differences in response to quantified intakes of ethanol, tolerance, on and off rates, and responses of recidivist drinkers.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA007614-06
Application #
2044040
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
1992-04-01
Project End
1995-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Sansum Diabetes Research Institute
Department
Type
DUNS #
City
Santa Barbara
State
CA
Country
United States
Zip Code
93105
Peterson, K P; Bowers, C; Peterson, C M (1998) Prevalence of ethanol consumption may be higher in women than men in a university health service population as determined by a biochemical marker: whole blood-associated acetaldehyde above the 99th percentile for teetotalers. J Addict Dis 17:13-23
Braun, K P; Pearce, R B; Peterson, C M (1995) Acetaldehyde-serum protein adducts inhibit interleukin-2 secretion in concanavalin A-stimulated murine splenocytes: a potential common pathway for ethanol-induced immunomodulation. Alcohol Clin Exp Res 19:345-9
Braun, K P; Cody Jr, R B; Jones, D R et al. (1995) A structural assignment for a stable acetaldehyde-lysine adduct. J Biol Chem 270:11263-6
Chen, H M; Scott, B K; Braun, K P et al. (1995) Validated fluorimetric HPLC analysis of acetaldehyde in hemoglobin fractions separated by cation exchange chromatography: three new peaks associated with acetaldehyde. Alcohol Clin Exp Res 19:939-44
Halvorson, M R; Noffsinger, J K; Roberts, B D et al. (1994) Association of high density lipoprotein with whole blood-associated acetaldehyde levels. Alcohol 11:3-6
Chen, H M; Lin, W W; Ferguson, K H et al. (1994) Studies of the oxidation of ethanol to acetaldehyde by oxyhemoglobin using fluorigenic high-performance liquid chromatography. Alcohol Clin Exp Res 18:1202-6
Chen, H M; Peterson, C M (1994) Quantifying ethanol by high performance liquid chromatography with precolumn enzymatic conversion and derivatization with fluorimetric detection. Alcohol 11:577-82
Halvorson, M R; Campbell, J L; Sprague, G et al. (1993) Comparative evaluation of the clinical utility of three markers of ethanol intake: the effect of gender. Alcohol Clin Exp Res 17:225-9
Halvorson, M R; Noffsinger, J K; Peterson, C M (1993) Studies of whole blood-associated acetaldehyde levels in teetotalers. Alcohol 10:409-13
Wong, M K; Scott, B K; Peterson, C M (1992) Breath acetaldehyde following ethanol consumption. Alcohol 9:189-92

Showing the most recent 10 out of 17 publications